Eli Lilly to Invest $1 Billion in India, Establish New Hyderabad Hub

Eli Lilly and Company has unveiled plans to invest $1 billion in India over the coming years. The investment aims to enhance contract manufacturing capabilities across the country, a strategic move to bolster the company's supply chain and evolving portfolio.

Central to the initiative is the establishment of a new hub in Hyderabad, designed to offer advanced technical capabilities and oversight for Lilly's contract manufacturing network. Recruitment for this hub is underway, with roles available for engineers, chemists, and management positions, among others.

This significant investment underscores Lilly's intent to tap into India's skilled workforce to support its global growth. With a longstanding presence in India, Lilly continues to expand its footprint in Hyderabad, reinforcing the region's standing as a global healthcare innovation hub.

(With inputs from agencies.)